文献速递浆细胞疾病造血干细胞移植与细胞治疗

血清游离轻链骤升或是多发性骨髓瘤肿瘤溶解综合征的缺失环节

An upsurge of the serum free light chains as a possible missing link in tumour lysis syndrome in multiple myeloma.
PubMed 文献 · Br J Haematol · 2019-10-01

多发性骨髓瘤增殖率低,肿瘤溶解综合征(TLS)少见。本文报告三例骨髓瘤患者细胞毒治疗后发生TLS,均伴血清游离轻链(FLC)骤升,且三例均有侵袭性髓外浆细胞瘤。提示FLC突然释放而非缓慢分泌可能诱发暴发性管型肾病,是TLS未被识别的危险因素和潜在加重因素。

要点

  • 骨髓瘤患者细胞毒治疗后FLC骤升需警惕TLS。
  • 伴侵袭性髓外浆细胞瘤者TLS风险可能更高。
  • FLC突然释放可能诱发暴发性管型肾病并加重TLS。

核心结论

  • 骨髓瘤细胞突然释放FLC而非缓慢分泌,可能诱发暴发性管型肾病,是TLS未被识别的危险因素和潜在加重因素。

研究设计与样本

  • 本文报告三例多发性骨髓瘤患者细胞毒治疗后发生TLS的病例观察。

主要发现

  • 三例患者均在细胞毒治疗后发生TLS,其中两例发生在放疗后。
  • TLS发生与血清FLC骤升相关。
  • 三例患者均存在髓外浆细胞瘤,且较原发骨髓瘤表现出侵袭性特征。

临床怎么用

  • 骨髓瘤患者接受细胞毒治疗(含放疗)后应关注血清FLC骤升,警惕TLS及管型肾病。
  • 对伴侵袭性髓外浆细胞瘤的骨髓瘤患者,治疗后需加强TLS监测。

局限性

  • 本文为三例病例观察,样本量小,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Multiple myeloma (MM) is a slow-growing malignancy characterized by a low proliferation rate of plasma cells and a relatively rare incidence of tumour lysis syndrome (TLS). Three myeloma patients developed TLS following cytotoxic therapy (two after radiation treatment) that was associated with an abrupt increase of serum free light chains (FLC). All three patients demonstrated extramedullary plasmacytomas that exhibited aggressive features compared to the original myeloma. The findings suggested that an abrupt liberation (rather than slow secretion) of FLC from myeloma cells may trigger a fulminant cast nephropathy and present an unrecognized risk factor and potentially aggravating component of TLS.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Yavorkovsky LL, Jing W, Baker R, et al. An upsurge of the serum free light chains as a possible missing link in tumour lysis syndrome in multiple myeloma. Br J Haematol. 2019. PMID: 31573682. doi:10.1111/bjh.16231

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。